AAAAAA
Results: 1-25/35
Authors:
Kellogg, TA
Lazaron, V
Wasiluk, KR
Dunn, DL
Citation: Ta. Kellogg et al., Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures, SHOCK, 15(2), 2001, pp. 124-129
Authors:
Crisman, SA
Molz, FJ
Dunn, DL
Sappington, FC
Citation: Sa. Crisman et al., Application procedures for the electromagnetic borehole flowmeter in shallow unconfined aquifers, GR WATER M, 21(4), 2001, pp. 96-100
Authors:
Gruessner, AC
Sutherland, DER
Dunn, DL
Najarian, JS
Humar, A
Kandaswamy, R
Gruessner, RWG
Citation: Ac. Gruessner et al., Pancreas after kidney transplants in posturemic patients with type I diabetes mellitus, J AM S NEPH, 12(11), 2001, pp. 2490-2499
Authors:
Zyzanski, SJ
Crabtree, BF
Miller, WL
Jaen, CR
Flocke, SA
Kelly, RB
Gillanders, WR
Gilchrist, V
Chao, J
Shank, JC
Dunn, DL
Medalie, JH
Langa, D
Aita, V
Goodwin, MA
Gotler, RS
Ballou, LB
Corrigan, CM
Jaen, L
Patzke, S
Powers, FF
Schneeberger, KL
Warner, K
Zronek, S
Blankfield, R
Bloom, H
Gilchrist, V
Haas, G
Kellner, P
Lee, SK
Lindes, C
McCluskey, D
Mettee, T
Miller, A
Rabovsky, M
Wilkinson, A
Citation: Sj. Zyzanski et al., Conducting the direct observation of primary care study - Insights from the process of conducting multimethod transdisciplinary research in communitypractice, J FAM PRACT, 50(4), 2001, pp. 345-352
Authors:
Kandaswamy, R
Humar, A
Payne, WD
Dunn, DL
Sutherland, DER
Matas, AJ
Citation: R. Kandaswamy et al., Risk factors for kidney transplant acute rejection: A multivariate analysis, TRANSPLAN P, 33(1-2), 2001, pp. 1112-1112
Authors:
Kandaswamy, R
Gillingham, K
Humar, A
Payne, WD
Dunn, DL
Sutherland, DER
Najarian, JS
Matas, AJ
Citation: R. Kandaswamy et al., Impact of HLA-ABDR match on chronic rejection in kidney transplants, TRANSPLAN P, 33(1-2), 2001, pp. 1292-1292
Authors:
Sutherland, DER
Gruessner, RGW
Humar, A
Kandaswamy, R
Najarian, JS
Dunn, DL
Gruessner, A
Citation: Der. Sutherland et al., Pretransplant immunosuppression for pancreas transplants alone in nonuremic diabetic recipients, TRANSPLAN P, 33(1-2), 2001, pp. 1656-1658
Authors:
Lazaron, V
Leslie, DB
Wasiluk, KR
Dunn, DL
Citation: V. Lazaron et al., Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor-mediated process, SURGERY, 130(2), 2001, pp. 192-197
Authors:
Dunn, DL
Citation: Dl. Dunn, Endotoxin prophylaxis - Reply, SURGERY, 129(2), 2001, pp. 240-241
Authors:
Matas, AJ
Payne, WD
Sutherland, DER
Humar, A
Gruessner, RWG
Kandaswamy, R
Dunn, DL
Gillingham, KJ
Najarian, JS
Citation: Aj. Matas et al., 2,500 living donor kidney transplants: A single-center experience, ANN SURG, 234(2), 2001, pp. 149-164
Authors:
Sutherland, DER
Gruessner, RWG
Dunn, DL
Matas, AJ
Humar, A
Kandaswamy, R
Mauer, SM
Kennedy, WR
Goetz, FC
Robertson, RP
Gruessner, AC
Najarian, JS
Citation: Der. Sutherland et al., Lessons learned from more than 1,000 pancreas transplants at a single institution, ANN SURG, 233(4), 2001, pp. 463-501
Authors:
Nichols, RL
Graham, DR
Barriere, SL
Rodgers, A
Wilson, SE
Zervos, M
Dunn, DL
Kreter, B
Citation: Rl. Nichols et al., Treatment of hospitalized patients with complicated Gram-positive skin andskin structure infections - Two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin (Reprinted from The Journal of Antimicrobial Chemotherapy, vol 44, pg 263-273, 1999), FORMULARY, 35, 2000, pp. S36-S47
Authors:
Dunn, DL
Citation: Dl. Dunn, Bacteremia associated with central venous catheter infection is not an independent predictor of outcomes - Invited commentary, J AM COLL S, 190(6), 2000, pp. 680-681
Authors:
Matas, AJ
Gillingham, K
Payne, WD
Humar, A
Dunn, DL
Sutherland, DER
Najarian, JS
Citation: Aj. Matas et al., Should I accept this kidney?, CLIN TRANSP, 14(1), 2000, pp. 90-95
Authors:
Matas, AJ
Gillingham, KJ
Humar, A
Dunn, DL
Sutherland, DER
Najarian, JS
Citation: Aj. Matas et al., Immunologic and nonimmunologic factors - Different risks for cadaver and living donor transplantation, TRANSPLANT, 69(1), 2000, pp. 54-58
Authors:
Martone, WJ
Nichols, WJ
Christou, NV
Barie, PS
Wilson, SE
Condon, RE
Lee, JT
Linden, PK
Malangoni, MA
Newell, K
Dellinger, EP
Rotstein, OD
Ledger, WJ
Bohnen, JMA
Fry, DE
Ginzburg, E
Gorbach, SL
Dunn, DL
Chambers, HF
Citation: Wj. Martone et al., Risk factors and surveillance for surgical wound infections, SURGERY, 128(4), 2000, pp. S2-S13
Authors:
Nichols, RL
Gorbach, SL
Wilson, SE
Hardin, WD
Barie, PS
Fry, DE
Condon, RE
Malangoni, MA
Fabian, TC
Dellinger, EP
Bohnen, JMA
Ledger, WJ
Dunn, DL
Ginzburg, E
Citation: Rl. Nichols et al., Current trends in antibiotic prophylaxis in surgery, SURGERY, 128(4), 2000, pp. S14-S18
Authors:
Nichols, RL
Martone, WJ
Wilson, SE
Chambers, HF
Fry, DE
Dunn, DL
Gorbach, SL
Condon, RE
Newell, K
Dellinger, EP
Rotstein, OD
Christou, NV
Ginzburg, E
Hardin, WD
Malangoni, MA
Ledger, WJ
Barie, PS
Linden, PK
Citation: Rl. Nichols et al., Diagnosis and treatment of uncomplicated and complicated surgical infections, SURGERY, 128(4), 2000, pp. S19-S30
Authors:
Weiss, CA
Wasiluk, KR
Kellogg, TA
Dunn, DL
Citation: Ca. Weiss et al., Bactericidal and endotoxin neutralizing activity of a peptide derived fromLimulus antilipopolysaccharide factor, SURGERY, 128(2), 2000, pp. 339-344
Authors:
Dunn, DL
Citation: Dl. Dunn, Diagnosis and treatment of opportunistic infections in immunocompromised surgical patients, AM SURG, 66(2), 2000, pp. 117-125
Authors:
Dunn, DL
Citation: Dl. Dunn, Diagnosis and treatment of infection, SURGERY: BASIC SCIENCE AND CLINICAL EVIDENCE, 2000, pp. 193-219
Authors:
West, M
Pirenne, J
Chavers, B
Gillingham, K
Sutherland, DER
Dunn, DL
Matas, AJ
Citation: M. West et al., Clostridium difficile colitis after kidney and kidney-pancreas transplantation, CLIN TRANSP, 13(4), 1999, pp. 318-323
Authors:
Nichols, RL
Graham, DR
Barriere, SL
Rodgers, A
Wilson, SE
Zervos, M
Dunn, DL
Kreter, B
Citation: Rl. Nichols et al., Treatment of hospitalized patients with complicated Gram-positive skin andskin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin (vol 44, pg 263, 1999), J ANTIMICRO, 44(4), 1999, pp. 585-585
Authors:
Nichols, RL
Graham, DR
Barriere, SL
Rodgers, A
Wilson, SE
Zervos, M
Dunn, DL
Kreter, B
Citation: Rl. Nichols et al., Treatment of hospitalized patients with complicated Gram-positive skin andskin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin, J ANTIMICRO, 44(2), 1999, pp. 263-273
Authors:
Dunn, DL
Citation: Dl. Dunn, Augmented enhancement of in vitro production of inflammatory cytokines..., CRIT CARE M, 27(5), 1999, pp. 859-860